title: 2015 American Society of Clinical Oncology annual meeting.
authors.forename: Sean
authors.initials: S
authors.lastname: Cleghorn
mesh_terms: D000230:Adenocarcinoma / Q000188:drug therapy; D000077192:Adenocarcinoma of Lung; D000911:Antibodies, Monoclonal / Q000627:therapeutic use; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D000068258:Bevacizumab / Q000627:therapeutic use; D002289:Carcinoma, Non-Small-Cell Lung / Q000188:drug therapy; D003226:Congresses as Topic; D006801:Humans; D008175:Lung Neoplasms / Q000188:drug therapy*; D008495:Medical Oncology; D008654:Mesothelioma / Q000188:drug therapy; D047428:Protein Kinase Inhibitors / Q000627:therapeutic use; D055752:Small Cell Lung Carcinoma / Q000188:drug therapy; D012955:Societies, Medical; D014481:United States
chemical_list: D000911:Antibodies, Monoclonal; D000970:Antineoplastic Agents; D047428:Protein Kinase Inhibitors; D000068258:Bevacizumab